News and views
Our magazine
Insights gives you all the news from the labs, hot topics, health tips and personal stories. Available as a free monthly email or twice-yearly magazine.
Sign up for more news and views
Campaigning
We want men with prostate cancer to get better diagnosis, better treatment and better support. But we can’t do it alone: we need your help.
Join the fightUrine test shows promise for spotting aggressive cancers
Promising new research finds a chemical signature in urine that can predict the presence and aggressiveness of prostate cancer. However, more tests are needed to compare it against new MRI scans.
The art of precision medicine
Prostate cancer is finally catching up with similar diseases in having treatments that can target an individual’s specific cancer – and it’s thanks to the game-changing research that you help us fund.
New blood test results reveal potential of liquid biopsies to deliver precision medicine for prostate cancer
Researchers at the Institute of Cancer Research have created a powerful new three-in-one blood test, which could help doctors monitor whether a treatment is working and how a man's cancer is responding. We examine the results and find out why it's another step in the creation of targeted treatments for prostate cancer.
New Movember funds will turn treatment research into clinical reality
Our £1.5m of Movember Foundation Translational Awards will ensure four groundbreaking projects make it through the labs and into clinical trials.
The exciting truth about biomarkers
BLOG: Despite a misleading Telegraph article, the science of biomarkers is still well worth getting excited about, says Sophie Lutter.
Prostate cancer in your genes: what can genetic testing tell us?
BLOG: Sophie Lutter explores the ins and outs of genetic testing for prostate cancer, and what it might mean for men and their families, in terms of improving treatment and identifying those at risk.
Expert insight: Leading prostate cancer scientist explains hottest topics at national cancer research conference
BLOG: Earlier this month the UK’s biggest gathering of cancer experts took place in Liverpool – the NCRI cancer conference. We sponsored a session and went along to represent the organisation, meet experts and hear from the cutting edge of cancer research. But we also wanted to find out what other prostate cancer experts made of it.
Genetic testing could identify men at six-fold increased risk of prostate cancer
Scientists now have a better understanding of the inherited risk of prostate cancer, after an international study identified 23 new genetic variants (changes in the DNA sequence) associated with increased risk of the disease.
Genetic screening could identify men with higher risk of advanced prostate cancer
PRESS COMMENT: Screening men with a family history of prostate cancer for a range of gene mutations can identify those who are at high risk of aggressive forms of the disease and in need of lifelong monitoring, a new study has shown.
Flicking the switch on cancer cell growth
Prostate Cancer UK funded scientists at Newcastle University have found a new trick that prostate cancer cells use to escape from the body’s usual methods of controlling cell growth. This may help to explain why some treatments don’t work as well as expected.